COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital

被引:6
作者
Ranhel, David [1 ]
Ribeiro, Ana [1 ]
Batista, Judite [1 ]
Pessanha, Maria [1 ]
Cristovam, Elisabete [1 ]
Duarte, Ana [1 ]
Dias, Ana [1 ]
Coelho, Luis [1 ]
Monteiro, Filipa [1 ]
Freire, Pedro [1 ]
Verissimo, Cristina [2 ]
Sabino, Raquel [2 ,3 ]
Toscano, Cristina [1 ]
机构
[1] Ctr Hosp Lisboa Ocidental, P-1349019 Lisbon, Portugal
[2] Natl Hlth Inst Dr Ricardo Jorge, Infect Dis Dept, P-1649016 Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Inst Saude Ambiental, P-1649028 Lisbon, Portugal
关键词
COVID-19; intensive care unit; Aspergillus; invasive pulmonary aspergillosis; COVID-19-associated invasive pulmonary aspergillosis; COVID-19;
D O I
10.3390/jof7100881
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Invasive pulmonary aspergillosis (IPA) has become a recognizable complication in coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs). Alveolar damage in the context of acute respiratory distress syndrome (ARDS) appears to be the culprit in facilitating fungal invasion in COVID-19 patients, leading to a COVID-19-associated pulmonary aspergillosis (CAPA) phenomenon. From November 2020 to 15 February 2021, 248 COVID-19 patients were admitted to our ICUs, of whom ten patients (4% incidence) were classified as either probable (six) or possible (four) CAPA cases. Seven patients had positive cultural results: Aspergillus fumigatus sensu stricto (five), A. terreus sensu stricto (one), and A. welwitschiae (one). Five patients had positive bronchoalveolar lavage (BAL) and galactomannan (GM), and two patients had both positive cultural and GM criteria. All but two patients received voriconazole. Mortality rate was 30%. Strict interpretation of classic IPA definition would have resulted in eight overlooked CAPA cases. Broader diagnostic criteria are essential in this context, even though differentiation between Aspergillus colonization and invasive disease might be more challenging. Herein, we aim to raise awareness of CAPA in view of its potential detrimental outcome, emphasizing the relevance of a low threshold for screening and early antifungal treatment in ARDS patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Proven COVID-19-associated pulmonary aspergillosis in patients with severe respiratory failure
    Fortarezza, Francesco
    Boscolo, Annalisa
    Pezzuto, Federica
    Lunardi, Francesca
    Jesus Acosta, Manuel
    Giraudo, Chiara
    Del Vecchio, Claudia
    Sella, Nicolo
    Tiberio, Ivo
    Godi, Ilaria
    Cattelan, Annamaria
    Vedovelli, Luca
    Gregori, Dario
    Vettor, Roberto
    Viale, Pierluigi
    Navalesi, Paolo
    Calabrese, Fiorella
    MYCOSES, 2021, 64 (10) : 1223 - 1229
  • [42] COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis
    Jonas Frost
    Maximilian Gornicec
    Alexander C. Reisinger
    Philipp Eller
    Martin Hoenigl
    Juergen Prattes
    Mycopathologia, 2024, 189
  • [43] COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis
    Frost, Jonas
    Gornicec, Maximilian
    Reisinger, Alexander C.
    Eller, Philipp
    Hoenigl, Martin
    Prattes, Juergen
    MYCOPATHOLOGIA, 2024, 189 (01)
  • [44] Invasive Aspergillosis in the Intensive Care Unit
    Zubovskaia, Anna
    Vazquez, Jose A.
    JOURNAL OF FUNGI, 2025, 11 (01)
  • [45] Invasive Aspergillosis in the Intensive Care Unit
    Townsend, Liam
    Martin-Loeches, Ignacio
    DIAGNOSTICS, 2022, 12 (11)
  • [46] COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
    Fekkar, Arnaud
    Neofytos, Dionysios
    Nguyen, Minh-Hong
    Clancy, Cornelius J.
    Kontoyiannis, Dimitrios P.
    Lamoth, Frederic
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1376 - 1378
  • [47] Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?
    Reizine, Florian
    Pinceaux, Kieran
    Lederlin, Mathieu
    Autier, Brice
    Guegan, Helene
    Gacouin, Arnaud
    Luque-Paz, David
    Boglione-Kerrien, Christelle
    Bacle, Astrid
    Le Dare, Brendan
    Launey, Yoann
    Lesouhaitier, Mathieu
    Painvin, Benoit
    Camus, Christophe
    Mansour, Alexandre
    Robert-Gangneux, Florence
    Belaz, Sorya
    Le Tulzo, Yves
    Tadie, Jean-Marc
    Maamar, Adel
    Gangneux, Jean-Pierre
    JOURNAL OF FUNGI, 2021, 7 (05)
  • [48] COVID-19-Associated Pulmonary Aspergillosis, March-August 2020
    Salmanton-Garcia, Jon
    Sprute, Rosanne
    Stemler, Jannik
    Bartoletti, Michele
    Dupont, Damien
    Valerio, Maricela
    Garcia-Vidal, Carolina
    Falces-Romero, Iker
    Machado, Marina
    de la Villa, Sofia
    Schroeder, Maria
    Hoyo, Irma
    Hanses, Frank
    Ferreira-Paim, Kennio
    Giacobbe, Daniele Roberto
    Meis, Jacques F.
    Gangneux, Jean-Pierre
    Rodriguez-Guardado, Azucena
    Antinori, Spinello
    Sal, Ertan
    Malaj, Xhorxha
    Seidel, Danila
    Cornely, Oliver A.
    Koehler, Philipp
    EMERGING INFECTIOUS DISEASES, 2021, 27 (04) : 1077 - 1086
  • [49] Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
    Egger, Matthias
    Bussini, Linda
    Hoenigl, Martin
    Bartoletti, Michele
    JOURNAL OF FUNGI, 2022, 8 (04)
  • [50] Severe COVID-19 in the intensive care unit: a case series
    Hori Hariyanto
    Corry Quando Yahya
    Ronald Christian Agustinus Aritonang
    Journal of Medical Case Reports, 15